I haven't posted in a while, but there are three news-worthy items that need attention.
1. Afrezza, the super-fast-acting insulin I wrote about after it got FDA approval last year is finally on the market. I discuss it on this new web page: Afrezza - Inhaled Insulin. If you try Afrezza, please email me a report at mailto:email@example.com with a title, "Afrezza report." You can also post about it in the comment section here.
Note: Many people have been emailing me that they are having trouble replying to this blog. It is a Google problem. Usually using Explorer for your browser will fix it.
2. Diabetic Mice: I've never been a fan of mouse research. Now a disturbing new finding confirms just how flawed it has been. It turns out that the engineered mouse model for diabetes that has been used in 250+ studies also has an abnormal human growth hormone gene that causes the mouse to have extremely abnormal levels of that hormone, which causes them to produce insulin in a highly abnormal fashion.
Mainstream scientists are calling these "tainted mice."
You can read the details here: Medical News Today: Diabetes Research Takes an Unexpected Turn
3. The Glycemic Index. Research has found that the Glycemic Index is uselss for people for diabetes. I've discussed that at length, HERE. Now it turns out, it's also useless for normal people. Carbs, it turns out are carbs for them, too. Fast or slow, doesn't matter. Eating lower GI foods did not produce better health outcomes.
Ignore the headline and read the report here: Glycemic Index Shouldn't Concern People Without Diabetes
Bottom line, the Glycemic index shouldn't concern ANYONE. It's junk science made popular by grain companies afraid of losing customers to healthier, lower carb diets.